Address
Atlas Venture
25 First Street
Suite 303
Cambridge, MA 02141
United States
Website
Recent investment activity
KANDO id: 24121
Company type
Early-stage venture capital firm that creates and invests in biotechnology startup companies in the US.Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 51 - 75 of 117| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
JenaValve Technology GmbH | A medical device company focused on developing transcatheter-delivered aortic valve systems to treat patients suffering from aortic valve disease. | Series A Initial investment | |||
|
|
Kalido Inc | The leading provider of business-driven data governance software. | Series C Initial investment 13,500,000 (USD 13,500,000) | |||
|
|
KDS | A leading international SaaS provider of Travel & Expense (T&E) management systems. | N/A Initial investment | |||
|
|
Keas Inc | Provider of online care plans for individuals. | Series A Initial investment 10,000,000 (USD 10,000,000) | |||
|
|
LearnBoost Inc | Provder of an online education platform and software. | Seed Initial investment 975,000 (USD 975,000) | |||
|
Lilliputian Systems Inc | Developer of fuel cell system and chips for consumer electronics devices. | N/A Initial investment 28,000,000 (USD 28,000,000) | |||
|
|
Liquid Machines Inc | Series C Initial investment | ||||
|
|
LiveVault Corp | N/A Initial investment | ||||
|
|
LuckyLabs Inc | Developer of casual games for mobile devices. | N/A Initial investment | |||
|
|
Marathon Technologies Corp | Provider of fault-tolerant and disaster recovery software solutions for physical and virtual servers. | Series B Initial investment 12,000,000 (USD 12,000,000) | |||
|
|
Mascoma Corp | A biofuel company that develops innovative technology for the low-cost conversion of abundant biomass to renewable fuels and chemicals. | N/A Initial investment 30,000,000 (USD 30,000,000) | |||
|
|
MiaSole Inc (Miasolé Inc) | Series D Initial investment | ||||
|
|
Miragen Therapeutics Inc | Ddeveloper of cardiovascular and muscle disease therapeutics based on microRNA biology. | Series B Follow-on investment | |||
|
|
Miragen Therapeutics Inc | Ddeveloper of cardiovascular and muscle disease therapeutics based on microRNA biology. | Series A Initial investment 8,000,000 (USD 8,000,000) | |||
|
|
Momenta Pharmaceuticals Inc | Momenta is a leader in the analysis, characterization, and design of complex pharmaceutical products. | N/A Initial investment | |||
|
MOO Print Ltd | A pioneer in web-to-print technology. | Series A Initial investment 5,000,000 (USD 5,000,000) | |||
|
|
NaviNet Inc | America’s largest real-time healthcare communications network. | N/A Initial investment | |||
|
|
Netonomy Inc | Provides online account management, e-commerce, and electronic bill analysis for the communications industry. | N/A Initial investment | |||
|
|
Nimbus Discovery LLC | A computational technology-based drug discovery company. | Seed Initial investment | |||
|
|
NovaMed Inc | N/A Initial investment | ||||
|
|
NTRglobal | A Spanish-based developer of software as a service solutions, offers remote support, remote access and remote systems management solutions. | Series C Initial investment 34,000,000 (USD 34,000,000) | |||
|
|
NxStage Medical Inc | Hemofiltration for kidney failure | N/A Initial investment | |||
|
|
Objective Logistics Inc | A retail/restaurant-focused software company. | N/A Initial investment 1,500,000 (USD 1,500,000) | |||
|
|
Omnia Communications Inc | N/A Initial investment | ||||
|
|
On-Q-ity Inc | A diagnostic company, engages in developing non-invasive diagnostic monitoring tools for use in the treatment of individual cancer patients. | Series A Initial investment 26,000,000 (USD 26,000,000) |